title: Low-dose ATG is effective in treatment of acute rejection episodes.
authors.affiliation: Department of Nephrology & Urology Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
authors.forename: R K
authors.initials: RK
authors.lastname: Sharma
authors.forename: A
authors.initials: A
authors.lastname: Kumar
authors.forename: J
authors.initials: J
authors.lastname: Kumar
authors.forename: A
authors.initials: A
authors.lastname: Gupta
authors.forename: S
authors.initials: S
authors.lastname: Gulati
authors.forename: A P
authors.initials: AP
authors.lastname: Sharma
authors.forename: M
authors.initials: M
authors.lastname: Bhandari
authors.forename: A
authors.initials: A
authors.lastname: Kumar
mesh_terms: D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents